2090 Prognostic score (REGOSCORE) for survival after Regorafenib (RE) treatment for patients (pts) with pretreated metastatic colorectal cancer (mCRC). (September 2015) - Kramar, A.; Paule, B.; Burtin, P; Tougeron, D.; Desseigne, F.; Dourthe, L.M.; Wallet, J.; Etienne, PL.; Mineur, L.; Becuwe, C.; Maes, P; Dauba, J.; et al.